safeguarding the Future

Cord Blood & Cord Tissue
Safeguarding
The Future
Mary & Ryan Schneider’s
story
For close to a decade, nationally recognized
Cryo-Cell Cord Blood Educator Mary Schneider
has been championing the benefits of storing
umbilical cord blood. But when she gave birth
to her son, Ryan 12 years ago, she had no idea
the turn her life would take.
Although Mary’s pregnancy and Ryan’s birth
were both completely normal, she began
to notice that Ryan was experiencing some
developmental challenges. Then, when Ryan
was just a year old, she received the diagnosis
that no parent ever wants to hear—he had a
mild to moderate case of cerebral palsy. It’s
not hard to imagine how this changed Mary’s
world. However, she had had the foresight to
store Ryan’s umbilical cord blood, and after
extensive research, Mary found that cord blood
could be used to treat cerebral palsy.
In fact, in 2005 when Ryan was 3, he became
the first child to receive his own cord blood at
Duke University, in what is now an ongoing
study for children with cerebral palsy that have
access to their own cord blood. Ryan was
cleared of all his symptoms shortly after his
transplant and is a happy, healthy, 12 year-old
today.
“A brighter future is ahead for Ryan because I
made the decision to bank his precious cord
blood stem cells. Now many other children
could also have the opportunity to live fuller
lives when their parents make the same wise
choice. Banking your child’s stem cells is the
best insurance.”
For more information contact Cryo-Cell International at
800.786.7235 or visit Cryo-Cell.com
Corporate Mission
Cryo-Cell International’s mission is to provide our
clients with the premier stem cell cryopreservation
service and to support research and development
initiatives for regenerative medicine.
Cord blood education is now mandated in many
states. For a complimentary consultation or
to request more information, contact
Cryo-Cell International at
800.786.7235 or [email protected]
Regarding umbilical cord tissue, all private blood banks’ activities for New York State residents are limited to collection,
processing, and long-term storage of umbilical cord tissue stem cells. The possession of a New York State license for
such collection, processing and long-term storage does not indicate approval or endorsement of possible future uses
or future suitability of these cells. In order to preserve more types and quantity of umbilical cord stem cells and to
maximize possible future health options, Cryo-Cell’s umbilical cord tissue service provides expectant families with the
opportunity to cryogenically store their newborn’s umbilical cord tissue cells contained within substantially intact cord
tissue. Should umbilical cord tissue cells be considered for potential utilization in a future therapeutic application, further
laboratory processing may be necessary. ©2015 Cryo-Cell International, Inc. All rights reserved. COT0198_0515D
800.786.7235 • Cryo-Cell.com
Why banking your baby’s cord
blood is important
The Cryo-Cell Difference
Founded in 1989, Cryo-Cell International was the
world’s first private cord blood bank to separate
and store stem cells in 1992. Today, over 500,000
parents from 87 countries have entrusted Cryo-Cell
International to help safeguard their families’ future
health. Cryo-Cell International is the world’s leading
cord blood bank for the following reasons:
Once considered medical waste, the umbilical
cord is now helping families safeguard their
future health. Cord blood is rich in hematopoietic
stem cells, the building blocks of our blood and
immune systems. Therapeutic uses for these cells
are increasing.
Superior Processing
Technology
MOre of what you want
Cryo-Cell International
recovers more
healthy stem cells 4
which means better
therapeutic outcomes
for your baby.
•Cryo-Cell International is the industry’s
most highly accredited cord blood bank.
All Cord Blood transpl ants worldwide
•Cryo-Cell International is the first major
cord blood bank to adopt the industry’s
premium processing method, enabling
parents to obtain the best possible cord
blood collection for their babies2.
30000
28000
26000
24000
22000
20000
18000
16000
14000
12000
10000
8000
6000
4000
2000
0
less of what you don’t
Cryo-Cell International
reduces red blood cell
(RBC) contamination.
Less red blood cells
post processing means
less toxic side effects.
•Cryo-Cell International’s collection kit
safeguards stem cells during transportation
approximately 30 times longer than other
private cord blood banks when exposed to
extreme temperatures.
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
•100% of Cryo-Cell International’s specimens
have been viable when thawed for
therapeutic use. No other cord blood bank
makes this statement.
2011
•Umbilical cord blood stem cells are a perfect
match for your baby and a close match for
other family members
•Cryo-Cell International, through its research
affiliate, holds more cord blood patents than
any other cord blood bank3.
•Stem cells are being used to treat nearly 80
diseases including leukemia, lymphoma,
immune deficiency and genetic disorders.
•Cryo-Cell International uses the only FDA
approved sterile collection bag.
What Does Cord tissue
and the Future Hold?
Cryo-Cell International also offers the storage
of umbilical cord tissue, which is rich in
mesenchymal stem cells. These cells give rise
to structural tissues such as bone, cartilage and
muscle and are currently being used in many
clinical trials.
•Cryo-Cell International’s $75,000 payment
guarantee of cord blood engraftment is the
best in the industry.
•The number of diseases currently being treated
by stem cells has been increasing. The current
odds of undergoing any stem cell transplant by
age 70 is 1 in 2171.
tomorrow
•Leading scientists believe cord blood stem
cells can be cryogenically stored indefinitely.
Cord blood and cord tissue
are currently being used in
•Compared to bone marrow, cord blood stem
cells are immunologically immature and less
prone to produce graft versus host disease,
have less risk of transmitting infection, are
more easily matched to a recipient, have a
potent graft versus tumor effect, and are more
readily available in a shorter time period.
Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of
hematopoietic stem cell transplantation in the US. Biol Blood Marrow Transplant. 2008;14:316-22.
1
Today
Cord blood stem cells
have been used in over
30,000 transplants
For more information contact Cryo-Cell at
800.786.7235 or visit Cryo-Cell.com
2
Based on Cryo-Cell’s PrepaCyte CB processing technology. SLCBB data presented at the 16th
Annual ISCT Meeting May 23-26, 2010. Henderson, C., et al., ISCT Annual Meeting, Philadelphia,
PA, 2010. Alcaina, P., et al., EBMT Annual Meeting, Paris, France, 2011; Regan, D., et al., AABB
Annual Meeting, San Diego, CA, 2011.
Through our ownership in Saneron CCEL Therapeutics.
3
4
Colony-forming units
many clinical trials to treat:
•Cerebral palsy
•Autism
•Heart disease
worldwide to treat
•Diabetes
illnesses including:
•Alzheimer’s
• Cancers
• Immune System
Deficiencies
• Genetic Diseases
• Blood Disorders
•Parkinson’s
•Cirrhosis of the liver
•Sickle cell anemia
•Ulcerative colitis